相关实验视频

Updated: Jun 9, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

389

无法切除的肝细胞癌:通过动脉化学栓塞结合伦巴替尼与编程死亡-1抑制相结合是一种可能的方法

Fei-Yu Zhao1, Dong-Yu Wang2, Nian-Song Qian3

  • 1Department of Thoracic Oncology, Respiratory and Critical Care Medicine, The Eighth Medical Center of People's Liberation Army General Hospital, Beijing 100853, China.

World journal of gastrointestinal oncology
|October 30, 2024
PubMed
概括

通过动脉的化学栓塞与伦瓦替尼和PD-1抑制剂相结合,对不可切除的肝细胞癌有希望. 然而,需要进一步的研究来证实这种三重治疗方法的有效性和安全性.

关键词:
肝细胞癌是肝细胞癌.伦瓦提尼布 (Lenvatinib) 是一种药物.编程死亡 1 编程死亡 1通过动脉化学栓塞的跨动脉化疗.

更多相关视频

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.3K
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

5.5K

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K